2024 Q2 Form 10-Q Financial Statement

#000155673924000027 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $224.1M $233.6M
YoY Change -10.87% -4.86%
Cost Of Revenue $75.50M $79.98M
YoY Change -17.34% -11.86%
Gross Profit $148.6M $153.6M
YoY Change -7.18% -0.75%
Gross Profit Margin 66.31% 65.76%
Selling, General & Admin $117.3M $122.5M
YoY Change -9.37% -1.22%
% of Gross Profit 78.91% 79.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $14.07M $14.55M
YoY Change -10.18% -5.69%
% of Gross Profit 9.47% 9.47%
Operating Expenses $117.3M $122.5M
YoY Change -9.37% -1.22%
Operating Profit $31.34M $31.13M
YoY Change 2.05% 1.13%
Interest Expense -$12.18M -$13.36M
YoY Change -174.73% -181.02%
% of Operating Profit -38.85% -42.91%
Other Income/Expense, Net -$5.416M -$3.954M
YoY Change 980.33%
Pretax Income $12.17M $13.82M
YoY Change -3.06% 0.08%
Income Tax $6.618M $5.397M
% Of Pretax Income 54.4% 39.05%
Net Earnings $5.548M $8.424M
YoY Change -65.28% -9.56%
Net Earnings / Revenue 2.48% 3.61%
Basic Earnings Per Share $0.15 $0.24
Diluted Earnings Per Share $0.15 $0.22
COMMON SHARES
Basic Shares Outstanding 35.83M shares 35.56M shares
Diluted Shares Outstanding 37.63M shares 37.99M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.52M $14.39M
YoY Change 1.8% -6.5%
Cash & Equivalents $15.52M $14.39M
Short-Term Investments
Other Short-Term Assets $5.822M $49.07M
YoY Change -62.58% 100.59%
Inventory
Prepaid Expenses
Receivables $193.7M $208.7M
Other Receivables $1.516M $2.855M
Total Short-Term Assets $260.6M $275.0M
YoY Change -15.77% -29.23%
LONG-TERM ASSETS
Property, Plant & Equipment $37.81M $37.84M
YoY Change -1.98% -0.73%
Goodwill $301.0M $299.6M
YoY Change -47.17% -46.96%
Intangibles $6.640M $11.63M
YoY Change -78.8% -64.79%
Long-Term Investments
YoY Change
Other Assets $27.25M $162.7M
YoY Change -7.96% 412.18%
Total Long-Term Assets $524.9M $511.8M
YoY Change -33.72% -34.69%
TOTAL ASSETS
Total Short-Term Assets $260.6M $275.0M
Total Long-Term Assets $524.9M $511.8M
Total Assets $785.5M $786.8M
YoY Change -28.67% -32.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.661M $19.74M
YoY Change 17.98% 119.86%
Accrued Expenses $110.2M $76.97M
YoY Change 3.36% -39.5%
Deferred Revenue $25.67M $45.85M
YoY Change 27.47% -4.05%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $52.50M $52.50M
YoY Change -25.0% -25.0%
Total Short-Term Liabilities $228.1M $239.7M
YoY Change -4.13% -19.25%
LONG-TERM LIABILITIES
Long-Term Debt $289.6M $295.1M
YoY Change -20.32% -23.1%
Other Long-Term Liabilities $12.45M $85.00M
YoY Change -41.24% 252.91%
Total Long-Term Liabilities $374.3M $380.1M
YoY Change -18.44% -20.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $228.1M $239.7M
Total Long-Term Liabilities $374.3M $380.1M
Total Liabilities $602.4M $619.8M
YoY Change -13.56% -20.26%
SHAREHOLDERS EQUITY
Retained Earnings -$484.2M -$489.8M
YoY Change 126.68% 113.32%
Common Stock $638.0K $633.0K
YoY Change 3.24% 2.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $183.1M $167.1M
YoY Change
Total Liabilities & Shareholders Equity $785.5M $786.8M
YoY Change -28.67% -32.88%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $5.548M $8.424M
YoY Change -65.28% -9.56%
Depreciation, Depletion And Amortization $14.07M $14.55M
YoY Change -10.18% -5.69%
Cash From Operating Activities $22.22M $5.438M
YoY Change -12.6% -83.17%
INVESTING ACTIVITIES
Capital Expenditures $8.952M $7.278M
YoY Change 0.81% 41.71%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$8.952M -$7.278M
YoY Change -50.25% 41.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.956M -1.558M
YoY Change -49.96% -90.86%
NET CHANGE
Cash From Operating Activities 22.22M 5.438M
Cash From Investing Activities -8.952M -7.278M
Cash From Financing Activities -8.956M -1.558M
Net Change In Cash 4.314M -3.398M
YoY Change -141.22% -134.57%
FREE CASH FLOW
Cash From Operating Activities $22.22M $5.438M
Capital Expenditures $8.952M $7.278M
Free Cash Flow $13.27M -$1.840M
YoY Change -19.79% -106.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
395053000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
79983000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90747000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
153641000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
154808000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
70091000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
76343000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52416000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47680000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
122507000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
124023000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
31134000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
30785000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
13359000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
16488000 usd
CY2024Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
1581000 usd
CY2023Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
121000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2373000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-366000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13821000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13810000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5397000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4496000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8424000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9314000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-265000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2188000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8159000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7126000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35186121 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34606864 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37985785 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36981652 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14394000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18216000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
17829000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14926000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
204119000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
205503000 usd
CY2024Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
39000 usd
CY2023Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
35000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4578000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2909000 usd
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2855000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3085000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
31606000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17771000 usd
CY2024Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
15106000 usd
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
16722000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2359000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2662000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
275017000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
266868000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37836000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38599000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
299626000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
302400000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11626000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18788000 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
131357000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
128051000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
31373000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28464000 usd
CY2024Q1 us-gaap Assets
Assets
786835000 usd
CY2023Q4 us-gaap Assets
Assets
783170000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
19743000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10348000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
89142000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
105903000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
52500000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
70000000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7953000 usd
CY2024Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
24515000 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
23979000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45846000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44558000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8402000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
239699000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
263190000 usd
CY2024Q1 us-gaap Senior Long Term Notes
SeniorLongTermNotes
239331000 usd
CY2023Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
230052000 usd
CY2024Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
55737000 usd
CY2023Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
48845000 usd
CY2024Q1 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
70828000 usd
CY2023Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
69388000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14174000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18995000 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
380070000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
367280000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63306246 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35826908 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62660783 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35302746 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
633000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
627000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1159754000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1151259000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
27479338 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
27358037 shares
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
488087000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
485793000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15456000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-15191000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-489778000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-498202000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
167066000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
152700000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
786835000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
783170000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
152700000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
918000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5289000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-265000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8424000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
167066000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
382267000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
267000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5393000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2188000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9314000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8424000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9314000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14553000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15431000 usd
CY2024Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
4849000 usd
CY2023Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
2688000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1310000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1361000 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3110000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1675000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7475000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5755000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5289000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5393000 usd
CY2024Q1 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
1581000 usd
CY2023Q1 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
121000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2373000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
881000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3152000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
756000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9750000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16268000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1670000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-463000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18169000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17367000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5754000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6515000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1189000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2711000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5438000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32311000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7278000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
5136000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7278000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5136000 usd
CY2024Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
9368000 usd
CY2023Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
35000000 usd
CY2024Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
205351000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
272857000 usd
CY2024Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
198459000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
255179000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
918000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
267000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1558000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17055000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-723000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-290000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4121000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9830000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20530000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18180000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16409000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28010000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
11911000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
15008000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1915000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-992000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s consolidated financial statements requires management to make estimates and assumptions about future events that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. The results of those estimates form the basis for making judgments about the carrying values of certain assets and liabilities.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of reported amounts that rely on significant estimates include revenue recognition, allowance for credit losses, assets acquired and liabilities assumed in business combinations, capitalized costs to obtain a contract, certain amounts relating to the accounting for income taxes, including valuation allowance, indemnification asset, stock-based compensation expense, operating lease right-of-use assets and operating lease liabilities, accrued service credits, and pension obligations. Significant estimates are also used in determining the recoverability and fair value of fixed assets and capitalized software, operating lease right-of-use assets, goodwill and intangible assets.</span></div>
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14394000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15395000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2015000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
12615000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16409000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28010000 usd
CY2023Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
5129000 usd
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
268800000 usd
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
67000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
302400000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2774000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
299626000 usd
CY2023 us-gaap Number Of Reporting Units
NumberOfReportingUnits
4 reporting_unit
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
28500000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
29700000 usd
CY2023Q1 thry Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
800000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
566004000 usd
CY2024Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
2 reporting_unit
CY2023 us-gaap Number Of Reporting Units
NumberOfReportingUnits
4 reporting_unit
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1028438000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1016812000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11626000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P1Y3M18D
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1034751000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1015963000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18788000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P1Y4M24D
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5400000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6200000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
9170000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1889000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
395000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
131000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
41000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11626000 usd
CY2023Q4 thry Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
14961000 usd
CY2022Q4 thry Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
14799000 usd
CY2024Q1 thry Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
5970000 usd
CY2023Q1 thry Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
3847000 usd
CY2024Q1 thry Accounts Receivable And Contract With Customer Allowance For Credit Loss Writeoff
AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteoff
3063000 usd
CY2023Q1 thry Accounts Receivable And Contract With Customer Allowance For Credit Loss Writeoff
AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteoff
5420000 usd
CY2024Q1 thry Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
17868000 usd
CY2023Q1 thry Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
13226000 usd
CY2024Q1 thry Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
6000000 usd
CY2023Q1 thry Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
3800000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
17800000 usd
CY2024Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
100000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
13200000 usd
CY2023Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
100000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
37892000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
57357000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
36909000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37889000 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
12170000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
8832000 usd
CY2024Q1 thry Accrued Service Credits Current
AccruedServiceCreditsCurrent
2171000 usd
CY2023Q4 thry Accrued Service Credits Current
AccruedServiceCreditsCurrent
1825000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
89142000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
105903000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8169000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
9316000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
347568000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
348897000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
52500000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
70000000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
295068000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
278897000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
1300000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1100000 usd
CY2024Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
4824000 usd
CY2023Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
3504000 usd
CY2024Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3243000 usd
CY2023Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3383000 usd
CY2024Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1581000 usd
CY2023Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
121000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5289000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5393000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5289000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5393000 usd
CY2024Q1 thry Common Stock Number Of Shares Entitled Per Rsu
CommonStockNumberOfSharesEntitledPerRSU
1 shares
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
300000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
270943 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
113620 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8424000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9314000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35186121 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34606864 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8424000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9314000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35186121 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34606864 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2799664 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2374788 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37985785 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36981652 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.390
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.326
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17800000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17100000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
9500000 usd
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
9000000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
15600000 usd
CY2018Q4 thry Number Of Petitions Filed
NumberOfPetitionsFiled
3 petition
CY2018Q4 thry Number Of Cases Consolidated By Court
NumberOfCasesConsolidatedByCourt
3 case
CY2024Q1 thry Transaction Costs
TransactionCosts
0 usd
CY2023Q1 thry Transaction Costs
TransactionCosts
373000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
100000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-700000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
233624000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
153641000 usd
CY2024Q1 thry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
54114000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
245555000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
154808000 usd
CY2023Q1 thry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
58469000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13821000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13810000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
13359000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
16488000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14553000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15431000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5289000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5393000 usd
CY2024Q1 thry Restructuring Charges And Integration Expenses
RestructuringChargesAndIntegrationExpenses
5265000 usd
CY2023Q1 thry Restructuring Charges And Integration Expenses
RestructuringChargesAndIntegrationExpenses
5340000 usd
CY2024Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
1581000 usd
CY2023Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
121000 usd
CY2024Q1 thry Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
0 usd
CY2023Q1 thry Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
756000 usd
CY2024Q1 thry Other Income Loss
OtherIncomeLoss
-246000 usd
CY2023Q1 thry Other Income Loss
OtherIncomeLoss
-2269000 usd
CY2024Q1 thry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
54114000 usd
CY2023Q1 thry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
58469000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
233624000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
245555000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
233624000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
245555000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001556739-24-000027-index-headers.html Edgar Link pending
0001556739-24-000027-index.html Edgar Link pending
0001556739-24-000027.txt Edgar Link pending
0001556739-24-000027-xbrl.zip Edgar Link pending
exhibit311-2024q110xq.htm Edgar Link pending
exhibit312-2024q110xq.htm Edgar Link pending
exhibit321-2024q110xq.htm Edgar Link pending
exhibit322-2024q110xq.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thry-20240331.htm Edgar Link pending
thry-20240331.xsd Edgar Link pending
thry-20240331_def.xml Edgar Link unprocessable
thry-20240331_lab.xml Edgar Link unprocessable
thry-20240331_htm.xml Edgar Link completed
thry-20240331_cal.xml Edgar Link unprocessable
thry-20240331_pre.xml Edgar Link unprocessable